Paul G. Fisher

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 737 citations · Full text

The Taverna workflow suite: designing and executing workflows of Web Services on the desktop, web or in the cloud

Katherine Wolstencroft, Robert Haines, Donal Fellows et al. · Nucleic Acids Research · 2013 · 675 citations · Full text

Engineering, Complex Analysis Pipelines, Software Engineering +21

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint et al. · The Lancet Oncology · 2019 · 472 citations · Full text

Neuro-oncology, Tumoral Pathology, Pediatric Brain Tumors +12

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

Sharareh Gholamin, Siddhartha S. Mitra, Abdullah H. Feroze et al. · Science Translational Medicine · 2017 · 413 citations

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma

Michelle Monje, Siddhartha S. Mitra, Morgan E. Freret et al. · Proceedings of the National Academy of Sciences · 2011 · 333 citations · Full text

Brain Development, Pathology, High-grade Gliomas +17